# Pectoralis and Serratus Muscle Blocks

> **NCT03743194** · PHASE4 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 210 (actual)

## Conditions studied

- Post Operative Pain Control

## Interventions

- **DRUG:** Exparel 266 MG Per 20 ML Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03743194
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-14
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-03-14
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2025-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03743194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03743194, "Pectoralis and Serratus Muscle Blocks". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03743194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*